Hennion & Walsh Asset Management »

Intellia Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.6M 150k 17.27
2025-06-30 $1.4M 153k 9.38
2025-03-31 $1.0M 147k 7.11
2024-12-31 $1.4M 121k 11.66
2024-09-30 $1.1M 54k 20.55
2024-06-30 $893k 40k 22.38

More positions owned by Hennion & Walsh Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Proshares Tr S&p 500 High Inc (ISPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Investment Grade (IGEB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Ishares Tr Pfd And Incm Sec (PFF)
Pimco Municipal Income Fund II (PML)
Alphabet Cap Stk Cl A (GOOGL)
Nuveen Muni Value Fund (NUV)

View all positions for Hennion & Walsh Asset Management

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics